69 results
8-K
AKLI
Akili Inc
30 Apr 24
Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results
8:14am
of digital therapeutics among healthcare providers, caregivers, and patients; the Company’s ability to defend its intellectual property and satisfy various
8-K
EX-99.1
AKLI
Akili Inc
30 Apr 24
Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results
8:14am
to successfully create, and navigate, a new category of medicine and to achieve broad adoption of digital therapeutics among healthcare providers, caregivers
8-K
EX-99.1
AKLI
Akili Inc
26 Feb 24
Japanese Product Now Under Review for Nationwide Marketing Approval
9:04am
the SHIONOGI Group Vision of “Building Innovation Platforms to Shape the Future of Healthcare” by transforming into a “Healthcare as a Service (HaaS)” company
PRE 14A
d9ta41u0g2ppbbn y2gf
23 Feb 24
Preliminary proxy
7:57am
8-K
EX-99.1
6l6gc4
21 Feb 24
Akili Announces Release Date for Fourth Quarter and Full Year 2023
4:11pm
8-K
2ul0z2s2y5ego
5 Jan 24
Departure of Directors or Certain Officers
4:17pm
8-K
EX-99.1
rhray
18 Dec 23
EndeavorRx®, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17
8:10am
8-K
EX-99.1
fuo w9utp7
9 Nov 23
Akili Reports Third Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
50zd5e7 ao9yp9r
6 Oct 23
Akili Announces Leadership Transition
7:07am
8-K
EX-99.1
m4aqn5
6 Oct 23
Akili Announces Leadership Transition
7:07am
424B3
squ 0bytq1q
13 Sep 23
Prospectus supplement
8:11am
8-K
EX-99.1
zqi3l 60movhqwoanuqx
13 Sep 23
Akili Announces Business Transformation, Focusing on Non-prescription Model
8:05am
8-K
ntvfkrlrefh2jlz wq
13 Sep 23
Akili Announces Business Transformation, Focusing on Non-prescription Model
8:05am
POS AM
mb2ox9 qtjiluvttk
5 Sep 23
Prospectus update (post-effective amendment)
4:20pm
424B3
ip8vapm1kj3y fvrnsl1
10 Aug 23
Prospectus supplement
4:17pm
424B3
lle8g91vjr1qx2
10 Aug 23
Prospectus supplement
4:13pm